NCT01535872View on ClinicalTrials.gov

Study of Dehydroepiandrosterone Treatment for Poor Responders in In Vitro Fertilization Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

November 30, 2017

Conditions
InfertilityPoor Responder to IVF Treatment
Interventions
DIETARY_SUPPLEMENT

Dehydroepiandrosterone

DHEA in 25mg capsule. 1 capsule taken 3 times daily for up to 5 months.

Trial Locations (1)

229899

KK Women's and Children's Hospital, Singapore

All Listed Sponsors
lead

KK Women's and Children's Hospital

OTHER_GOV

NCT01535872 - Study of Dehydroepiandrosterone Treatment for Poor Responders in In Vitro Fertilization Patients | Biotech Hunter | Biotech Hunter